Tiny molecules called tRNA halves may contribute to prostate cancer cell growth

Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...
EurekAlert!

Novel therapy using engineered immune cells to kill prostate cancer earns $1.8 million Department of Defense grant

Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently ...
News Medical

Study identifies immune biomarkers for personalized therapies in pediatric germ cell tumors

A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos Cancer Hospital) in the state of São Paulo, Brazil, has identified possible ...
EurekAlert!

Chinese Medical Journal Article Review the role of metabolic reprogramming as a contributor to prostate cancer disease progression

This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.